10 January 2020
The global vaccine market is a steady grower, while also providing an absolutely vital medical service to billions of people around the world. This makes the vaccines market a strong candidate for investment, as long as a company understands the risks involved. This is what Visiongain specializes in. We do in-depth vaccine market research, along with many other industries, to bring you the information needed to make strong decisions.
Our reports touch on many areas of the topic; here is a brief summary of the current state of the vaccine market research.
Vaccines specifically formulated substances that improve human immunity to a variety of diseases. Each vaccine is tailored to a specific disease, usually utilizing a dead or dormant form of that disease to train the body's immune system to fight it. Currently, the primary market segmentations are for live attenuated vaccines, inactivated vaccines, and subunit/recombinant vaccines.
Vaccines Market Global Outlook
On the whole, the vaccine market shows a growth rate of approximately 6.67% and is forecasted to remain there until the mid-2020s. Of the various market segments, live attenuated vaccines (which use live, but harmless, disease matter) is by far the most dominant, accounting for the majority of vaccines in use. The growth in this segment is projected to have a CAGR of 5.44% in the near future.
Of vaccines currently on the market, one strong growth area is in vaccines for the Human Papilloma Virus. HPV is a mild sexually transmitted disease which is also linked to cervical cancer, and its vaccine being increasingly mandated by world governments.
As such, growth in the vaccine market is seen as largely government-driven. States implement initiatives mandating vaccination, causing immediate boosts to the industry. This fuels research into new vaccines, which are then introduced to the market.
Major Challenges to The Global Vaccine Market
Expansion into developing nations has been a continual challenge. Many governments are at times disinterested in public health initiatives, or else lack the resources to implement widespread vaccination. There is also a substantial lack of education among the public and some lingering distrust of vaccines themselves. These issues create uncertainty in the ability of the market to grow globally.
In addition, the production of new vaccines is extremely expensive, with long and arduous regulations that must be cleared, slowing the introduction of new products.
Visiongain has far more insights to share. Click here to browse our selection of pharmaceutical market research.
The increasing rates of patent expiry lead to a counter-strategy of switching companies from Rx to OTC. In the US, according to the Consumer Healthcare Products Association, approximately 106 ingredients and dosage strengths have undergone a change from Rx to OTC to around 700 OTC products on the market.
23 September 2020
. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.
16 September 2020
Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.
14 September 2020
The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.